EMBC
Embecta Corp. Healthcare - Medical Instruments & Supplies Investor Relations →
Embecta Corp. (EMBC) closed at $5.29 as of 2026-09-18, trading 62.4% below its 200-week moving average of $14.06. This places EMBC in the extreme value zone. The stock moved further from the line this week, up from -65.2% last week. With a 14-week RSI of 73, EMBC is in overbought territory.
Trading volume is running at 1.1x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.42 ratio) is neutral — neither side is clearly dominating.
Over the past 186 weeks of data, EMBC has crossed below its 200-week moving average 1 time. On average, these episodes lasted 182 weeks.
With a market cap of $300 million, EMBC is a small-cap stock. The company generates a free cash flow yield of 46.1%, which is notably high. The stock trades at -0.5x book value.
Share count has increased 2.5% over three years, indicating dilution.
Over the past 3.7 years, a hypothetical investment of $100 in EMBC would have grown to $19, compared to $202 for the S&P 500. EMBC has returned -36.4% annualized vs 21.1% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -22.3% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: EMBC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After EMBC Crosses Below the Line?
Across 1 historical episodes, buying EMBC when it crossed below its 200-week moving average produced an average return of -51.0% after 12 months (median -51.0%), compared to +30.0% for the S&P 500 over the same periods. After 24 months, the average return was -54.0% vs +40.0% for the index.
Each line shows $100 invested at the moment EMBC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Dislocation Scores Experimental
Each score measures deviation from EMBC's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
EMBC has crossed below its 200-week MA 1 time
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2023 | Ongoing | 182+ | 80.6% | Ongoing | -78.6% |
Frequently Asked Questions
Is EMBC below its 200-week moving average?
Yes. As of 2026-09-18, Embecta Corp. (EMBC) is trading 62.4% below its 200-week moving average of $14.06. The current price is $5.29.
What is EMBC's 200-week moving average price?
Embecta Corp.'s 200-week moving average is $14.06 as of 2026-09-18. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when EMBC drops below its 200-week moving average?
EMBC has crossed below its 200-week moving average 1 time in our data. These episodes lasted 182 weeks on average.
Is EMBC a good value right now?
Here's what our data says about EMBC as of 2026-09-18: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 73 (overbought). Free cash flow yield is 46.1%. Price-to-book is -0.5x. This is not a buy or sell recommendation — always do your own research.
How does EMBC compare to the S&P 500?
Over the past 3.7 years, $100 invested in EMBC would have grown to $19, compared to $202 for the S&P 500. That's -36.4% annualized vs 21.1% for the index. EMBC has underperformed the broader market over this period.
Does EMBC pay a dividend?
Yes. Embecta Corp. currently pays a dividend yield of 77.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-09-18